五星体育直播 Spreading the Promise of Engineered Proteins at SynBioBeta Summit

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- 五星体育直播 (NASDAQ: CDXS), a leading protein engineering company, is contributing resources and expertise to communicate protein engineering鈥檚 vast potential at SynBioBeta鈥檚 Global Synthetic Biology Summit in San Francisco, Oct. 1鈥�3. SynBioBeta is a prominent network of biological engineers, investors, innovators and entrepreneurs.

鈥淭he optionality to design a new protein molecule is effectively infinite,鈥� said 五星体育直播 CEO John Nicols, a featured speaker at the conference. 鈥淥ur CodeEvolver庐 protein engineering platform technology melds artificial intelligence, machine learning and synthetic biology toolkits to continuously accelerate the identification of new value creating protein based products, targeting a wide range of industries and applications. We are excited to showcase CodeEvolver庐 and our growing list of real-world commercial success stories at this premier synthetic biology innovation networking event next week.鈥� CodeEvolver庐 is the company鈥檚 proprietary protein engineering platform.

五星体育直播, a gold sponsor of the summit, is either featured in or hosting the following events:

  • Successful Partnering in the Bioeconomy
    Fireside Chat
    October 2, 10:10-10:40 a.m.
    Nicols and Tate & Lyle CTO Michael Harrison will discuss their companies鈥� partnership and how vital successful partnering is to the industry.
  • Commercial Success of CodeEvolver庐
    Workshop
    October 2, 12:30鈥�1:15 p.m.
    Dipnath Baidyaroy, Ph.D., senior director of strategic alliances and business operations and Jonathan Vroom, Ph.D., principal scientist, explain how 五星体育直播 has used its unique CodeEvolver庐 protein engineering technology to rapidly gain success in commercial markets.
  • Wide Applications of Protein Engineering
    Breakout Session
    October 3, 2:30鈥�3:15 p.m.
    • Gjalt Huisman, Ph.D., senior vice president of strategic development, will moderate.
    • Matt Miller, Ph.D., senior scientist, will present: RNA polymerase for capped messenger RNA manufacturing & DNA polymerase for next-gen sequencing.
    • Kerryn McCluskie, Ph.D., senior director of translational biology, will present: Orally administrable biotherapeutics.
    • Oscar Alvizo, Ph.D., director of computational biology, will present: AI/machine learning in protein engineering.

Attendees are also invited to visit 五星体育直播 at booth #212.

About 五星体育直播
五星体育直播 is a leading protein engineering company that applies its proprietary CodeEvolver庐 technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. 五星体育直播鈥� proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes. For more information, see .

Forward-Looking Statements
To the extent that statements contained in this press release are not descriptions of historical facts regarding 五星体育直播, they are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond 五星体育直播鈥� control and that could materially affect actual results. Additional information about factors that could materially affect actual results can be found in 五星体育直播鈥� Annual Report on Form 10-K filed with the Securities and Exchange Commission (鈥淪EC鈥�) on March 15, 2018 and Quarterly Report on Form 10-Q filed November 9, 2018, including under the caption 鈥淩isk Factors鈥� and in 五星体育直播鈥� other periodic reports filed with the SEC. 五星体育直播 expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law.

五星体育直播 Contact:
LHA Investor Relations
Jody Cain, 310-691-7100
jcain@lhai.com

Source: 五星体育直播

Released September 26, 2019